Morgan Stanley’s Octave Specialty Group OSG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.55M Buy
569,563
+334,317
+142% +$1.74M ﹤0.01% 4461
2026
Q1
$1.09M Sell
235,246
-703,466
-75% -$4.03M ﹤0.01% 5097
2025
Q4
$7.3M Buy
938,712
+744,588
+384% +$6.36M ﹤0.01% 3885
2025
Q3
$1.62M Sell
194,124
-263,507
-58% -$2.23M ﹤0.01% 4909
2025
Q2
$3.25M Sell
457,631
-400,409
-47% -$2.98M ﹤0.01% 4391
2025
Q1
$7.51M Buy
858,040
+360,085
+72% +$3.79M ﹤0.01% 3586
2024
Q4
$6.3M Sell
497,955
-244,958
-33% -$2.95M ﹤0.01% 3804
2024
Q3
$8.33M Buy
742,913
+184,305
+33% +$2.16M ﹤0.01% 3566
2024
Q2
$7.16M Buy
558,608
+78,069
+16% +$1.19M ﹤0.01% 3595
2024
Q1
$7.51M Sell
480,539
-70,651
-13% -$1.11M ﹤0.01% 3569
2023
Q4
$9.08M Sell
551,190
-27,655
-5% -$385K ﹤0.01% 3432
2023
Q3
$6.98M Sell
578,845
-242,795
-30% -$3.26M ﹤0.01% 3450
2023
Q2
$11.7M Sell
821,640
-203,254
-20% -$2.97M ﹤0.01% 3023
2023
Q1
$15.9M Buy
1,024,894
+682,857
+200% +$11.1M ﹤0.01% 2682
2022
Q4
$5.97M Buy
342,037
+8,490
+3% +$126K ﹤0.01% 3594
2022
Q3
$4.25M Sell
333,547
-98,801
-23% -$1.32M ﹤0.01% 3827
2022
Q2
$4.91M Sell
432,348
-696,485
-62% -$6.61M ﹤0.01% 3790
2022
Q1
$11.7M Sell
1,128,833
-128,301
-10% -$1.74M ﹤0.01% 2720
2021
Q4
$20.2M Sell
1,257,134
-292,375
-19% -$4.59M ﹤0.01% 2129
2021
Q3
$22.2M Buy
1,549,509
+1,134,167
+273% +$16.2M ﹤0.01% 1985
2021
Q2
$6.5M Sell
415,342
-1,039,506
-71% -$16.7M ﹤0.01% 3496
2021
Q1
$24.4M Sell
1,454,848
-112,771
-7% -$1.84M ﹤0.01% 1733
2020
Q4
$24.1M Buy
1,567,619
+1,407,707
+880% +$20.7M ﹤0.01% 1629
2020
Q3
$2.04M Buy
159,912
+10,909
+7% +$141K ﹤0.01% 3642
2020
Q2
$2.13M Sell
149,003
-757,229
-84% -$11.1M ﹤0.01% 3528
2020
Q1
$11.2M Sell
906,232
-28,423
-3% -$545K ﹤0.01% 1680
2019
Q4
$20.2M Buy
934,655
+143,966
+18% +$2.95M ﹤0.01% 1650
2019
Q3
$15.5M Sell
790,689
-86,744
-10% -$1.59M ﹤0.01% 1699
2019
Q2
$14.8M Buy
877,433
+249,229
+40% +$4.26M ﹤0.01% 1760
2019
Q1
$11.4M Buy
628,204
+60,114
+11% +$1.15M ﹤0.01% 1915
2018
Q4
$9.79M Buy
568,090
+207,915
+58% +$3.82M ﹤0.01% 2160
2018
Q3
$7.35M Sell
360,175
-136,996
-28% -$2.86M ﹤0.01% 2747
2018
Q2
$9.87M Sell
497,171
-381,627
-43% -$7.04M ﹤0.01% 2395
2018
Q1
$13.8M Buy
878,798
+719,097
+450% +$11.1M ﹤0.01% 2033
2017
Q4
$2.55M Buy
159,701
+68,800
+76% +$1.06M ﹤0.01% 3811
2017
Q3
$1.57M Sell
90,901
-131,144
-59% -$2.42M ﹤0.01% 4093
2017
Q2
$3.85M Buy
222,045
+24,489
+12% +$435K ﹤0.01% 3152
2017
Q1
$3.73M Sell
197,556
-156,911
-44% -$3.3M ﹤0.01% 3184
2016
Q4
$7.97M Buy
354,467
+326,695
+1,176% +$7.14M ﹤0.01% 2500
2016
Q3
$511K Sell
27,772
-4,764
-15% -$85.5K ﹤0.01% 4510
2016
Q2
$536K Sell
32,536
-68,737
-68% -$1.1M ﹤0.01% 4387
2016
Q1
$1.6M Buy
101,273
+39,278
+63% +$568K ﹤0.01% 3528
2015
Q4
$873K Sell
61,995
-213,391
-77% -$3.28M ﹤0.01% 4162
2015
Q3
$3.98M Sell
275,386
-166,714
-38% -$2.7M ﹤0.01% 2854
2015
Q2
$7.36M Sell
442,100
-7,562
-2% -$179K ﹤0.01% 2422
2015
Q1
$10.9M Sell
449,662
-202,065
-31% -$5.14M ﹤0.01% 1972
2014
Q4
$16M Sell
651,727
-221,151
-25% -$5.15M 0.01% 1653
2014
Q3
$19.3M Buy
872,878
+280,303
+47% +$6.59M 0.01% 1469
2014
Q2
$16.2M Buy
592,575
+228,387
+63% +$6.62M 0.01% 1605
2014
Q1
$11.3M Sell
364,188
-441,749
-55% -$12.2M ﹤0.01% 1859
2013
Q4
$19.8M Buy
805,937
+634,131
+369% +$13.3M 0.01% 1350
2013
Q3
$3.12M Sell
171,806
-168,073
-49% -$3.83M ﹤0.01% 2868
2013
Q2
$8.1M Buy
+339,879
New +$8.24M ﹤0.01% 1862

Other funds holding OSG

Morgan Stanley's OSG Position: Q2 2026 in Review

Morgan Stanley increased its Octave Specialty Group (OSG) stake by 142% in Q2 2026, buying an estimated $1.74M and bringing the position to 569,563 shares worth $3.55M. The position accounts for ﹤0.01% of the portfolio, ranked #4461.

Morgan Stanley first reported a position in OSG in Q2 2013 and has held it in 53 quarters since. The position peaked at $24.4M in Q1 2021. 148 funds tracked by Wall St. Rank hold OSG as of Q2 2026.

  • Morgan Stanley held 569,563 shares of Octave Specialty Group worth $3.55M as of Q2 2026.
  • Morgan Stanley bought 334,317 Octave Specialty Group shares in Q2 2026, an estimated $1.74M.
  • Octave Specialty Group made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #4461 holding.
  • Morgan Stanley first reported a position in Octave Specialty Group in Q2 2013 and has held it in 53 quarters since.
  • Morgan Stanley's Octave Specialty Group position peaked at $24.4M in Q1 2021.
  • 148 funds tracked by Wall St. Rank held Octave Specialty Group as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.